Immunopreparat

Immunopreparat is a prominent Russian biopharmaceutical enterprise and a key production branch of NPO Microgen, situated in Ufa. Established in 1905, it has evolved into one of the country's largest manufacturers of immunobiological preparations, including vaccines, toxoids, and human immunoglobulins. The facility is particularly noted for its significant contribution to the Russian National Immunization Schedule, producing high volumes of influenza vaccines such as Sovigripp. Additionally, Immunopreparat is a global leader in the production of bacteriophage-based therapies, offering alternatives to traditional antibiotics for various bacterial infections. As part of the Nacimbio holding under Rostec, the company plays a vital role in ensuring Russia's pharmaceutical sovereignty in the field of infectious disease prevention.